Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intercure Ltd (NQ: INCR ) 1.537 -0.003 (-0.19%) Streaming Delayed Price Updated: 3:58 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Intercure Ltd < Previous 1 2 3 Next > Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company September 14, 2024 InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A. Via Benzinga Top Seller Of Pharmaceutical Cannabis Outside US Grew By Double-Digits, Focuses On Germany August 30, 2024 Via Benzinga Topics Cannabis Exposures Cannabis InterCure Announces Expansion of its Strategic partnership with Cookies to Germany August 28, 2024 From InterCure Via Business Wire European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon July 18, 2024 Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling... Via Benzinga Topics Cannabis Exposures Cannabis 5 Value Stocks In The Healthcare Sector May 08, 2023 Via Benzinga Overview Of Value Stocks In The Healthcare Sector April 17, 2023 Via Benzinga Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ May 24, 2024 The potential rescheduling of cannabis in the U.S. Via Benzinga Topics Cannabis Exposures Cannabis InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference May 22, 2024 From InterCure Ltd. Via Business Wire InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion May 02, 2024 "Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges. Via Benzinga InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million May 01, 2024 From InterCure Ltd. Via Business Wire This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict April 01, 2024 Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany. Via Benzinga Topics Cannabis Exposures Cannabis InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million April 01, 2024 From InterCure Ltd. Via Business Wire InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint March 22, 2024 From InterCure Ltd. Via Business Wire Canndoc Reports Record Revenue Amid Cannabis Market Turmoil September 01, 2023 InterCure Ltd. (NASDAQ: INCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023, Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 24, 2023 August 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For August 18, 2023 August 18, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Stocks That Hit 52-Week Lows On Wednesday July 05, 2023 Wednesday's session saw 43 companies set new 52-week lows. Via Benzinga Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Medical Cannabis Company Better Is Suing InterCure For $35M June 15, 2023 Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQ: INCR) for $35 million. Via Benzinga InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details May 16, 2023 InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million)... Via Benzinga Marijuana Stock Movers For August 9, 2023 August 09, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Why Are Cannabis Stocks Trading Higher Today? April 27, 2023 Cannabis stocks shot up in Thursday's pre-market and are holding. Via Benzinga Marijuana Stock Movers For August 8, 2023 August 08, 2023 Via Benzinga InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countries April 20, 2023 InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership. Via Benzinga Cannabis Stock Movers For July 24, 2023 July 24, 2023 Via Benzinga Nasdaq Down 80 Points; VirTra Shares Spike Higher April 03, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P... Via Benzinga Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 03, 2023 Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday. Via Benzinga Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummet April 03, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
